Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 106276
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106276
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106276
Table 5 Procedure-related parameters
Characteristic | Infection group (n = 20) | Non-infection group (n = 57) | P value |
Mean operation time (minutes) | 142.5 ± 32.6 | 98.3 ± 25.7 | < 0.05 |
Operation time ≥ 120 minutes (%) | 70% (14/20) | 38.6% (22/57) | < 0.05 |
Volume of drug-eluting beads (mL) | 10.2 ± 2.1 | 9.8 ± 1.9 | > 0.05 |
Mean blood loss (mL) | 350.2 ± 120.5 | 250.1 ± 100.3 | < 0.05 |
Blood transfusion required (%) | 40% (8/20) | 24.6% (14/57) | < 0.05 |
Postoperative hospital stay (days) | 7.5 ± 2.3 | 5.8 ± 1.9 | < 0.05 |
Intraoperative complications (%) | 30% (6/20) | 17.5% (10/57) | > 0.05 |
Postoperative complications (%) | 50% (10/20) | 31.6% (18/57) | < 0.05 |
Mean number of lymph nodes removed | 12.5 ± 3.2 | 10.1 ± 2.8 | < 0.05 |
Positive lymph node ratio (%) | 45% (9/20) | 28.1% (16/57) | < 0.05 |
Mean tumor margin width (mm) | 5.2 ± 1.5 | 6.8 ± 1.2 | < 0.05 |
Invasive tumor (%) | 60% (12/20) | 40.4% (23/57) | < 0.05 |
- Citation: Wang G, Qi R. Analysis of risk factors for post-operative infection following drug-eluting trans arterial chemo embolization in hepatocellular carcinoma: A retrospective study. World J Gastrointest Surg 2025; 17(6): 106276
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/106276.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.106276